Underscoring the Importance of Allopurinol in Treating Gout: Results of a Food and Drug Administration-Mandated Safety Trial

Arthritis Rheumatol. 2020 Jun;72(6):877-878. doi: 10.1002/art.41266.

Authors

Nikolay P Nikolov¹, Sally Seymour¹, Rosemarie Neuner¹, Ya-Hui Hsueh¹, Eugenio Andraca-Carrera¹, Kusum Mistry¹

Affiliation

¹ Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, MD.

PMID: 32460423
DOI: 10.1002/art.41266

No abstract available

MeSH terms

Allopurinol / administration & dosage*
Febuxostat / administration & dosage*
Female
Gout / drug therapy*
Gout Suppressants / administration & dosage*
Humans
Male
Middle Aged
Product Surveillance, Postmarketing*
Randomized Controlled Trials as Topic
United States
United States Food and Drug Administration

Substances

Gout Suppressants
Febuxostat
Allopurinol